Hyodeoxycholic acid ameliorates cholestatic liver fibrosis by facilitating m6A-regulated expression of a novel anti-fibrotic target ETV4
{{output}}
Background & aims: Cholestatic liver fibrosis is a common pathological feature of various biliary tract diseases. the underlying pathological mechanisms are not fully elucidated, posing significant obstacles to the discovery of n... ...
